glp-1 plus gip Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Microdosing GLP-1/GIP for Women |

50 mg Phosphatidylethanolamine (from Sunflower Lecithin)

1,4,5 Conversely, diets rich in refined carbohydrates and processed foods may suppress this beneficial response

Glucagon-like peptide-1: A focus on neurodegenerative diseases

Several reviews examining GLP-1 users warn that reduced appetite can increase the risk of inadequate protein and micronutrient intake if nutrition is not actively managed

By demonstrating protective effects in a ciliopathy model, this study suggests that GLP-1 RAs may confer benefits beyond appetite suppression in patients with genetic obesity syndromes affecting ciliary function, further broadening the mechanistic rationale for targeting this pathway across diverse genetic etiologies of obesity

Back Kreymann, B, Ghatei, MA, Williams, G, Bloom, SR (5 Dec 1987), The Lancet , 330/8571, 1300-04